Stewart Abbot
Direttore Tecnico/Scientifico/R&S presso TURNSTONE BIOLOGICS CORP.
Patrimonio netto: - $ in data 30/04/2024
Profilo
Stewart Abbot is currently the Chief Scientific & Operating Officer at Adicet Therapeutics, Inc. and the Chief Scientific Officer at Turnstone Biologics Corp.
Previously, he held positions as the Senior Director-Research at Celgene Cellular Therapeutics, the Vice President-Translational Research at Fate Therapeutics, Inc., the SVP, Chief Operating & Scientific Officer at resTORbio, Inc., and the SVP, Chief Operating & Scientific Officer at Adicet Bio, Inc. Dr. Abbot obtained a doctorate degree from the University of London, an undergraduate degree from The University of Edinburgh, and a graduate degree from the University of Strathclyde.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 16/10/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Stewart Abbot
| Società | Posizione | Inizio |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Direttore Tecnico/Scientifico/R&S | 01/06/2021 |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Direttore operativo | 01/06/2018 |
Precedenti posizioni note di Stewart Abbot
| Società | Posizione | Fine |
|---|---|---|
| ADICET BIO, INC. | Direttore operativo | 11/06/2021 |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 26/06/2018 |
| ADICET BIO, INC. | Direttore operativo | - |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Corporate Officer/Principal | - |
Formazione di Stewart Abbot
| The University of Edinburgh | Undergraduate Degree |
| University of London | Doctorate Degree |
| University of Strathclyde | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Aziende private | 3 |
|---|---|
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Stewart Abbot
